{{Drugbox
| Watchedfields = changed
| verifiedrevid = 470472739
| IUPAC_name = (2''S'',5''R'')-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide
| image = Sulbactam.svg
| width = 150px
| image2 = Sulbactam ball-and-stick.png
| width2 = 200px
<!--Clinical data-->
| tradename = 
| Drugs.com = {{drugs.com|international|sulbactam}}
| MedlinePlus = a693021
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4  / S8 -->
| legal_CA = <!--                             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = POM
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status = 
| routes_of_administration = Injection
<!--Pharmacokinetic data-->
| bioavailability = 1
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = Kidneys?
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 68373-14-8
| ATC_prefix = J01
| ATC_suffix = CG01
| PubChem = 130313
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = 
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 115306
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = S4TF6I2330
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08533
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 9321
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 403
<!--Chemical data-->
| C=8 | H=11 | N=1 | O=5 | S=1
| molecular_weight = 233.243 g/mol
| smiles = O=S2(=O)C([C@@H](N1C(=O)C[C@H]12)C(=O)O)(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H11NO5S/c1-8(2)6(7(11)12)9-4(10)3-5(9)15(8,13)14/h5-6H,3H2,1-2H3,(H,11,12)/t5-,6+/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = FKENQMMABCRJMK-RITPCOANSA-N
}}

'''Sulbactam''' is a [[β-lactamase inhibitor]]. This [[drug]] is given in combination with [[β-lactam antibiotic]]s to inhibit [[β-lactamase]], an [[enzyme]] produced by [[bacteria]] that destroys the [[antibiotic]]s. <ref name="pmid17630699">{{cite journal  |vauthors=Totir MA, Helfand MS, Carey MP, etal |title=Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase |journal=Biochemistry |volume=46 |issue=31 |pages=8980–7 |date=August 2007 |pmid=17630699 |pmc=2596720 |doi=10.1021/bi7006146 |url=}}</ref>

==Mechanism==
Sulbactam is an irreversible inhibitor of β-lactamase; it binds to the enzyme and does not allow it to degrade the antibiotic.

==Uses==
Sulbactam is able to inhibit the most common forms of β-lactamase but is not able to interact with the [[AmpC cephalosporinase]]. Thus, it confers little protection against bacteria such as ''[[Pseudomonas aeruginosa]]'', ''[[Citrobacter]]'', ''[[Enterobacter]]'', and ''[[Serratia]]'', which often express this gene. 

In the [[United States]], sulbactam is combined to form [[ampicillin/sulbactam]].  It does possess some antibacterial activity when administered alone, but it is too weak to have any clinical importance.  Its use in the UK is restricted to hospitals.

Recently, its use in treating ''[[Acinetobacter]]'' [[septicemia]] is receiving renewed interest.

==See also==
* [[Tazobactam]]
* [[Clavulanic_acid|Clavulanate]]

== References ==
<references/>

== Further reading ==
*{{cite journal |author=Singh GS |title=Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam |journal=Mini Rev Med Chem |volume=4 |issue=1 |pages=93–109 |date=January 2004 |pmid=14754446 |doi= 10.2174/1389557043487547|url=http://www.eurekaselect.com/80621/article}}

{{PenicillinAntiBiotics}}

[[Category:Beta-lactamase inhibitors]]
[[Category:Lactams]]
[[Category:Sulfones]]
[[Category:Carboxylic acids]]


{{antibiotic-stub}}